Pegasus Biologics Inc.
This article was originally published in Start Up
Executive SummaryPegasus is developing a process that allows it to tailor the mechanical properties of collagen implants according to the need for either graft longevity or rapid ingrowth. It can also terminally sterilize implants without changing these properties. It is initially targeting orthopedic soft tissue repair and ACL repair.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.